| Net Cash Provided by (Used in) Operating Activities |
$9,574,525,000 |
USD |
28% |
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$8,946,911,000 |
USD |
-53% |
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,139,543,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares Authorized |
4,990,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
423,732,334 |
shares |
-0.87% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,831,783,000 |
USD |
1691% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$9,290,868,000 |
USD |
25% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$540,272,000 |
USD |
22% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$3,055,750,000 |
USD |
30% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$2,620,518,000 |
USD |
3.7% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$607,559,000 |
USD |
68% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$10,056,653,000 |
USD |
32% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$2,716,828,000 |
USD |
-0.72% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$2,883,733,000 |
USD |
16% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$457,390,000 |
USD |
5.7% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.04 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$304,658,000 |
USD |
-0.53% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$834,402,000 |
USD |
53% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$432,280,000 |
USD |
32% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$326,945,000 |
USD |
-2.7% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,515,478,000 |
USD |
32% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$701,342,000 |
USD |
0.88% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |